Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.

D'haeseleer M, Steen C, Hoogduin JM, van Osch MJ, Fierens Y, Cambron M, Koch MW, De Keyser J.

Acta Neurol Scand. 2013 Nov;128(5):e26-9. doi: 10.1111/ane.12129. Epub 2013 Apr 1.

PMID:
23550954
2.

Cerebral white matter blood flow and energy metabolism in multiple sclerosis.

Steen C, D'haeseleer M, Hoogduin JM, Fierens Y, Cambron M, Mostert JP, Heersema DJ, Koch MW, De Keyser J.

Mult Scler. 2013 Sep;19(10):1282-9. doi: 10.1177/1352458513477228. Epub 2013 Feb 21.

PMID:
23428956
3.

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.

Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

J Hepatol. 2013 Oct;59(4):651-7. doi: 10.1016/j.jhep.2013.05.008. Epub 2013 May 13.

PMID:
23680314
4.

Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.

Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.

Ann Neurol. 1994 Aug;36(2):157-65.

PMID:
8053651
5.

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients.

Mostert JP, Blaauw Y, Koch MW, Kuiper AJ, Hoogduin JM, De Keyser J.

Eur Radiol. 2008 Aug;18(8):1736-40. doi: 10.1007/s00330-008-0925-x. Epub 2008 Apr 4.

6.

Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.

Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, Raffer E, Niederhofer H, Ladurner G.

J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):357-63.

PMID:
16179658
7.

[Evaluation of cerebral metabolism by multi-voxel proton magnetic resonance spectroscopy imaging in chronic unilateral internal carotid artery occlusion].

Takayama H, Suga S, Kobayashi M, Sadanaga F, Hozumi A, Kanai Y, Okamura M, Mihara B.

No To Shinkei. 2000 Apr;52(4):307-12. Japanese.

PMID:
10793417
8.

Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.

Paling D, Thade Petersen E, Tozer DJ, Altmann DR, Wheeler-Kingshott CA, Kapoor R, Miller DH, Golay X.

J Cereb Blood Flow Metab. 2014 Jan;34(1):34-42. doi: 10.1038/jcbfm.2013.161. Epub 2013 Sep 18.

9.

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.

Neurology. 2005 Jan 25;64(2):304-10.

PMID:
15668429
10.

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.

Gadea M, Martínez-Bisbal MC, Marti-Bonmatí L, Espert R, Casanova B, Coret F, Celda B.

Brain. 2004 Jan;127(Pt 1):89-98. Epub 2003 Sep 23.

PMID:
14506072
11.

In vivo evidence of glutamate toxicity in multiple sclerosis.

Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D.

Ann Neurol. 2014 Aug;76(2):269-78. doi: 10.1002/ana.24202. Epub 2014 Jul 9.

12.

Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.

He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.

Radiology. 2005 Jan;234(1):211-7. Epub 2004 Nov 4.

PMID:
15528260
13.

Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity.

Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R.

Radiology. 2012 Oct;265(1):233-9. Epub 2012 Aug 21.

PMID:
22915599
14.

Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.

Hannoun S, Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Confavreux C, Cotton F, Sappey-Marinier D.

PLoS One. 2012;7(3):e32525. doi: 10.1371/journal.pone.0032525. Epub 2012 Mar 30. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/beed29e2-e61a-4d2f-8baa-ac53cf2fee7b.

15.

Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.

Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.

Neuroimage. 2006 Jan 15;29(2):637-42. Epub 2005 Aug 29.

PMID:
16126413
16.

White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?

Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J.

Acad Radiol. 2006 Feb;13(2):229-35.

PMID:
16428059
18.

The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack.

Yurtsever I, Hakyemez B, Taskapilioglu O, Erdogan C, Turan OF, Parlak M.

Eur J Radiol. 2008 Mar;65(3):421-6. Epub 2007 Jun 22.

PMID:
17587524
19.

Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).

Forn C, Belenguer A, Parcet-Ibars MA, Avila C.

J Clin Exp Neuropsychol. 2008 Oct;30(7):789-96. doi: 10.1080/13803390701779560. Epub 2008 Feb 13.

PMID:
18608672
20.

Cognitive dysfunction lateralizes with NAA in multiple sclerosis.

Pan JW, Krupp LB, Elkins LE, Coyle PK.

Appl Neuropsychol. 2001;8(3):155-60.

PMID:
11686650

Supplemental Content

Support Center